[
  {
    "ts": null,
    "headline": "Podcast: Chips, Banks Boost Markets",
    "summary": "TSMC reported record revenue for the fourth quarter. Plus: Boston Scientific shares drop after it announces it’s buying health-tech company Penumbra. ?Listen: Katherine Sullivan hosts the WSJ's Minute Briefing podcast.",
    "url": "https://finnhub.io/api/news?id=86821f3bc0474541078b8c88158d0a7ca9d9e5cc65d332bc46fdf3d92f601bd5",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1768516485,
      "headline": "Podcast: Chips, Banks Boost Markets",
      "id": 138137613,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BSX",
      "source": "Yahoo",
      "summary": "TSMC reported record revenue for the fourth quarter. Plus: Boston Scientific shares drop after it announces it’s buying health-tech company Penumbra. ?Listen: Katherine Sullivan hosts the WSJ's Minute Briefing podcast.",
      "url": "https://finnhub.io/api/news?id=86821f3bc0474541078b8c88158d0a7ca9d9e5cc65d332bc46fdf3d92f601bd5"
    }
  },
  {
    "ts": null,
    "headline": "Wall Street Snaps 2-Day Losing Streak as Semiconductors Shine, Bank Stocks Rise",
    "summary": "US equity benchmarks rebounded Thursday after a two-day slump, buoyed by gains in semiconductor and",
    "url": "https://finnhub.io/api/news?id=15d3cae7b4426a3220c032d84fe5c592c5f33dd59b8d41520317cc9783185112",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1768513102,
      "headline": "Wall Street Snaps 2-Day Losing Streak as Semiconductors Shine, Bank Stocks Rise",
      "id": 138132272,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BSX",
      "source": "Yahoo",
      "summary": "US equity benchmarks rebounded Thursday after a two-day slump, buoyed by gains in semiconductor and",
      "url": "https://finnhub.io/api/news?id=15d3cae7b4426a3220c032d84fe5c592c5f33dd59b8d41520317cc9783185112"
    }
  },
  {
    "ts": null,
    "headline": "Sector Update: Health Care Stocks Softer Late Afternoon",
    "summary": "Health care stocks declined late Thursday afternoon, with the NYSE Health Care Index and the State S",
    "url": "https://finnhub.io/api/news?id=61977f570a0a3f8001f5ae267595ad58928abde04dd09ca3de1cceb79c925a09",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1768509542,
      "headline": "Sector Update: Health Care Stocks Softer Late Afternoon",
      "id": 138132320,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BSX",
      "source": "Yahoo",
      "summary": "Health care stocks declined late Thursday afternoon, with the NYSE Health Care Index and the State S",
      "url": "https://finnhub.io/api/news?id=61977f570a0a3f8001f5ae267595ad58928abde04dd09ca3de1cceb79c925a09"
    }
  },
  {
    "ts": null,
    "headline": "Semiconductor, Bank Stocks Help Lift Equity Markets Intraday",
    "summary": "US benchmark equity indexes were higher intraday amid a surge in semiconductor stocks, with Goldman",
    "url": "https://finnhub.io/api/news?id=0f99c852ce956c4c4c04b5a91a805e103476f64c45176ff16a84ef6c34fc8a13",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1768504864,
      "headline": "Semiconductor, Bank Stocks Help Lift Equity Markets Intraday",
      "id": 138126243,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BSX",
      "source": "Yahoo",
      "summary": "US benchmark equity indexes were higher intraday amid a surge in semiconductor stocks, with Goldman",
      "url": "https://finnhub.io/api/news?id=0f99c852ce956c4c4c04b5a91a805e103476f64c45176ff16a84ef6c34fc8a13"
    }
  },
  {
    "ts": null,
    "headline": "Sector Update: Health Care Stocks Softer in Afternoon Trading",
    "summary": "Health care stocks declined Thursday afternoon, with the NYSE Health Care Index shedding 0.9% and th",
    "url": "https://finnhub.io/api/news?id=9ca942afcceb2dab0423eba065c7b6852befa216f772186a8a65d3bd45f96e6d",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1768502940,
      "headline": "Sector Update: Health Care Stocks Softer in Afternoon Trading",
      "id": 138126304,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BSX",
      "source": "Yahoo",
      "summary": "Health care stocks declined Thursday afternoon, with the NYSE Health Care Index shedding 0.9% and th",
      "url": "https://finnhub.io/api/news?id=9ca942afcceb2dab0423eba065c7b6852befa216f772186a8a65d3bd45f96e6d"
    }
  },
  {
    "ts": null,
    "headline": "JPM26: Boston Scientific acquires Penumbra in $14.5bn deal",
    "summary": "Boston will inherit products, including Penumbra’s Lightning thrombectomy systems, to advance its vascular care provision.",
    "url": "https://finnhub.io/api/news?id=43a292c22b5b2f988827fea3af748c629c403ceffebb020e66b2c9d4877983e7",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1768501387,
      "headline": "JPM26: Boston Scientific acquires Penumbra in $14.5bn deal",
      "id": 138126539,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BSX",
      "source": "Yahoo",
      "summary": "Boston will inherit products, including Penumbra’s Lightning thrombectomy systems, to advance its vascular care provision.",
      "url": "https://finnhub.io/api/news?id=43a292c22b5b2f988827fea3af748c629c403ceffebb020e66b2c9d4877983e7"
    }
  },
  {
    "ts": null,
    "headline": "Why Penumbra (PEN) Stock Is Trading Up Today",
    "summary": "Shares of medical device company Penumbra (NYSE:PEN) jumped 12.1% in the afternoon session after the company agreed to be acquired by Boston Scientific in a deal valued at approximately $14.5 billion.",
    "url": "https://finnhub.io/api/news?id=ccb469960771d296d5e3eddff3a16e28aa32589074d1a9abd59ad9b7675eee1f",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1768499497,
      "headline": "Why Penumbra (PEN) Stock Is Trading Up Today",
      "id": 138123084,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BSX",
      "source": "Yahoo",
      "summary": "Shares of medical device company Penumbra (NYSE:PEN) jumped 12.1% in the afternoon session after the company agreed to be acquired by Boston Scientific in a deal valued at approximately $14.5 billion.",
      "url": "https://finnhub.io/api/news?id=ccb469960771d296d5e3eddff3a16e28aa32589074d1a9abd59ad9b7675eee1f"
    }
  },
  {
    "ts": null,
    "headline": "Why Boston Scientific (BSX) Stock Is Down Today",
    "summary": "Shares of medical device company Boston Scientific (NYSE:BSX) fell 4.6% in the afternoon session after the company agreed to acquire Penumbra in a transaction valued at approximately $14.5 billion, marking its largest deal in two decades.",
    "url": "https://finnhub.io/api/news?id=d2ffa9b51333fa55ec0c3f500419b0ae440a7ed9b0cf0838e6e053ab615c581b",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1768499488,
      "headline": "Why Boston Scientific (BSX) Stock Is Down Today",
      "id": 138126541,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BSX",
      "source": "Yahoo",
      "summary": "Shares of medical device company Boston Scientific (NYSE:BSX) fell 4.6% in the afternoon session after the company agreed to acquire Penumbra in a transaction valued at approximately $14.5 billion, marking its largest deal in two decades.",
      "url": "https://finnhub.io/api/news?id=d2ffa9b51333fa55ec0c3f500419b0ae440a7ed9b0cf0838e6e053ab615c581b"
    }
  },
  {
    "ts": null,
    "headline": "Half of GLP-1 users ditch their injections — and some are turning to other weight-loss methods instead",
    "summary": "New research has found that 50% of patients regain the weight they lost if they stop taking Wegovy and Zepbound",
    "url": "https://finnhub.io/api/news?id=eebe177c3c4ea6e88afd8a7228f056aef53035e981c2b31d35e3ba6b323c4db3",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1768495860,
      "headline": "Half of GLP-1 users ditch their injections — and some are turning to other weight-loss methods instead",
      "id": 138151697,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BSX",
      "source": "Yahoo",
      "summary": "New research has found that 50% of patients regain the weight they lost if they stop taking Wegovy and Zepbound",
      "url": "https://finnhub.io/api/news?id=eebe177c3c4ea6e88afd8a7228f056aef53035e981c2b31d35e3ba6b323c4db3"
    }
  },
  {
    "ts": null,
    "headline": "Lightning Flashes As Boston Scientific Takes Over Penumbra For $14.5 Billion",
    "summary": "Boston Scientific will buy Penumbra for $14.5 billion, or $374 a share, expanding its cardiovascular reach. Penumbra stock jumped. Boston Scientific tumbled.",
    "url": "https://finnhub.io/api/news?id=fc2d09df79238f0581281ae2803d68bcb4bbb99393974656563963f2a8cf6bc6",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1768493014,
      "headline": "Lightning Flashes As Boston Scientific Takes Over Penumbra For $14.5 Billion",
      "id": 138121896,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BSX",
      "source": "Yahoo",
      "summary": "Boston Scientific will buy Penumbra for $14.5 billion, or $374 a share, expanding its cardiovascular reach. Penumbra stock jumped. Boston Scientific tumbled.",
      "url": "https://finnhub.io/api/news?id=fc2d09df79238f0581281ae2803d68bcb4bbb99393974656563963f2a8cf6bc6"
    }
  },
  {
    "ts": null,
    "headline": "Masimo Stock Declines Despite Solid Preliminary Q4 Revenues",
    "summary": "MASI posts strong fourth-quarter and full-year 2025 preliminary results with revenue and EPS above estimates, driven by core healthcare momentum.",
    "url": "https://finnhub.io/api/news?id=00e09a9a8105968696e3613e4083384c746f3f7fe6a4d4c1a556722ecec65314",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1768492380,
      "headline": "Masimo Stock Declines Despite Solid Preliminary Q4 Revenues",
      "id": 138122797,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BSX",
      "source": "Yahoo",
      "summary": "MASI posts strong fourth-quarter and full-year 2025 preliminary results with revenue and EPS above estimates, driven by core healthcare momentum.",
      "url": "https://finnhub.io/api/news?id=00e09a9a8105968696e3613e4083384c746f3f7fe6a4d4c1a556722ecec65314"
    }
  },
  {
    "ts": null,
    "headline": "Reasons to Retain QuidelOrtho Stock in Your Portfolio for Now",
    "summary": "QDEL's decent Q3 2025 results and expanding diagnostics portfolio support near-term growth despite respiratory reliance and payer risks.",
    "url": "https://finnhub.io/api/news?id=1c7c9855d157d62207203b8c4fe07c626f1e0662329fcd3107b02502c26b67fb",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1768491420,
      "headline": "Reasons to Retain QuidelOrtho Stock in Your Portfolio for Now",
      "id": 138122798,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BSX",
      "source": "Yahoo",
      "summary": "QDEL's decent Q3 2025 results and expanding diagnostics portfolio support near-term growth despite respiratory reliance and payer risks.",
      "url": "https://finnhub.io/api/news?id=1c7c9855d157d62207203b8c4fe07c626f1e0662329fcd3107b02502c26b67fb"
    }
  },
  {
    "ts": null,
    "headline": "PacBio Stock Up on HiFi Sequencing Adoption for Major SUDC Research",
    "summary": "PACB stock jumps as HiFi whole-genome sequencing becomes first-line in major SUDC research, highlighting adoption momentum.",
    "url": "https://finnhub.io/api/news?id=580cd0d168a1040fe8cc0a09b5c55ca056c409c0b394f87040ae9aa8eaabfdb2",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1768491300,
      "headline": "PacBio Stock Up on HiFi Sequencing Adoption for Major SUDC Research",
      "id": 138122799,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BSX",
      "source": "Yahoo",
      "summary": "PACB stock jumps as HiFi whole-genome sequencing becomes first-line in major SUDC research, highlighting adoption momentum.",
      "url": "https://finnhub.io/api/news?id=580cd0d168a1040fe8cc0a09b5c55ca056c409c0b394f87040ae9aa8eaabfdb2"
    }
  },
  {
    "ts": null,
    "headline": "Boston Scientific Agrees to Buy Penumbra in $14.6 Billion Cardiovascular Deal",
    "summary": "The cash-and-stock transaction values Penumbra at $374 per share and is expected to close later this year.",
    "url": "https://finnhub.io/api/news?id=a3dd6c1f939cbd081eef52966dbea89eea0f6a127d34e6bb5d6c763aed353600",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1768490223,
      "headline": "Boston Scientific Agrees to Buy Penumbra in $14.6 Billion Cardiovascular Deal",
      "id": 138121690,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BSX",
      "source": "Yahoo",
      "summary": "The cash-and-stock transaction values Penumbra at $374 per share and is expected to close later this year.",
      "url": "https://finnhub.io/api/news?id=a3dd6c1f939cbd081eef52966dbea89eea0f6a127d34e6bb5d6c763aed353600"
    }
  },
  {
    "ts": null,
    "headline": "Phibro Animal Health Stock Climbs 90.9% in a Year: What's Driving It?",
    "summary": "PAHC shares are up 90.9% this year, fueled by surging vaccine sales, new Brazil capacity and rapid growth across emerging markets.",
    "url": "https://finnhub.io/api/news?id=3eb24f3df9d6c070ebbcb021d7988cc7cd90659fd060245dfc99438f050a3357",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1768488120,
      "headline": "Phibro Animal Health Stock Climbs 90.9% in a Year: What's Driving It?",
      "id": 138122801,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BSX",
      "source": "Yahoo",
      "summary": "PAHC shares are up 90.9% this year, fueled by surging vaccine sales, new Brazil capacity and rapid growth across emerging markets.",
      "url": "https://finnhub.io/api/news?id=3eb24f3df9d6c070ebbcb021d7988cc7cd90659fd060245dfc99438f050a3357"
    }
  },
  {
    "ts": null,
    "headline": "Is it Apt to Retain HAE Stock in Your Portfolio for Now?",
    "summary": "Haemonetics' plasma and hemostasis franchises show solid growth potential, but macro headwinds and competition cloud the near-term outlook.",
    "url": "https://finnhub.io/api/news?id=c8af6bcf3e2931ecc12f4774c82c282af1996f7a171e957f7fff61f001fd51d2",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1768488120,
      "headline": "Is it Apt to Retain HAE Stock in Your Portfolio for Now?",
      "id": 138122800,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BSX",
      "source": "Yahoo",
      "summary": "Haemonetics' plasma and hemostasis franchises show solid growth potential, but macro headwinds and competition cloud the near-term outlook.",
      "url": "https://finnhub.io/api/news?id=c8af6bcf3e2931ecc12f4774c82c282af1996f7a171e957f7fff61f001fd51d2"
    }
  },
  {
    "ts": null,
    "headline": "BlackRock earnings, Spotify to raise premium price in the US",
    "summary": "Morning Brief Host Julie Hyman tracks several of the day's top trending stock tickers, including BlackRock (BLK), Boston Scientific's (BSX) deal to acquire Penumbra (PEN), and Spotify (SPOT). To watch more expert insights and analysis on the latest market action, check out more Morning Brief.",
    "url": "https://finnhub.io/api/news?id=1c038c26a04da550c43d147b8a2cac4c9454ce867f4a8d71cefd00b01183d2e5",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1768486983,
      "headline": "BlackRock earnings, Spotify to raise premium price in the US",
      "id": 138121685,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BSX",
      "source": "Yahoo",
      "summary": "Morning Brief Host Julie Hyman tracks several of the day's top trending stock tickers, including BlackRock (BLK), Boston Scientific's (BSX) deal to acquire Penumbra (PEN), and Spotify (SPOT). To watch more expert insights and analysis on the latest market action, check out more Morning Brief.",
      "url": "https://finnhub.io/api/news?id=1c038c26a04da550c43d147b8a2cac4c9454ce867f4a8d71cefd00b01183d2e5"
    }
  },
  {
    "ts": null,
    "headline": "Sector Update: Health Care Stocks Mixed Pre-Bell Thursday",
    "summary": "Health care stocks were mixed pre-bell Thursday, with the State Street Health Care Select Sector SPD",
    "url": "https://finnhub.io/api/news?id=6594748ee77410b2cde32b8717e5c5467ac97b71fcae5c90f023c1cbb735f11c",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1768486924,
      "headline": "Sector Update: Health Care Stocks Mixed Pre-Bell Thursday",
      "id": 138121692,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BSX",
      "source": "Yahoo",
      "summary": "Health care stocks were mixed pre-bell Thursday, with the State Street Health Care Select Sector SPD",
      "url": "https://finnhub.io/api/news?id=6594748ee77410b2cde32b8717e5c5467ac97b71fcae5c90f023c1cbb735f11c"
    }
  },
  {
    "ts": null,
    "headline": "Strong Chipmaker Earnings Lift Technology Sector, With US Equity Futures Mostly Higher Pre-Bell",
    "summary": "US equity futures were mostly higher ahead of Thursday's opening bell, with futures of technology-he",
    "url": "https://finnhub.io/api/news?id=e9983915c0710b061d4f94e5d2f0a5f02522b95eaccd20507034c755b81f6646",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1768485683,
      "headline": "Strong Chipmaker Earnings Lift Technology Sector, With US Equity Futures Mostly Higher Pre-Bell",
      "id": 138120928,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BSX",
      "source": "Yahoo",
      "summary": "US equity futures were mostly higher ahead of Thursday's opening bell, with futures of technology-he",
      "url": "https://finnhub.io/api/news?id=e9983915c0710b061d4f94e5d2f0a5f02522b95eaccd20507034c755b81f6646"
    }
  },
  {
    "ts": null,
    "headline": "Boston Scientific to Acquire Penumbra in $14.5 Billion Deal",
    "summary": "Boston Scientific (BSX) on Thursday agreed to acquire medical device company Penumbra (PEN) in a cas",
    "url": "https://finnhub.io/api/news?id=7f9f146cbd00ad9e0c3dd4c6e85232039162856091908e193eea9c709d8d0d7e",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1768485354,
      "headline": "Boston Scientific to Acquire Penumbra in $14.5 Billion Deal",
      "id": 138120929,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BSX",
      "source": "Yahoo",
      "summary": "Boston Scientific (BSX) on Thursday agreed to acquire medical device company Penumbra (PEN) in a cas",
      "url": "https://finnhub.io/api/news?id=7f9f146cbd00ad9e0c3dd4c6e85232039162856091908e193eea9c709d8d0d7e"
    }
  },
  {
    "ts": null,
    "headline": "Boston Scientific: Reclaiming Neurovascular Dominance Through Thrombectomy Precision",
    "summary": "Boston Scientific to buy Penumbra for $14.5B, expanding neurovascular thrombectomy, with long-term margin gains. Click here for more on BSX and PEN stocks.",
    "url": "https://finnhub.io/api/news?id=e65ede17258bc882b625ad3926a11922057f37e444ccd9bde58d80dc4c7212a7",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1768484755,
      "headline": "Boston Scientific: Reclaiming Neurovascular Dominance Through Thrombectomy Precision",
      "id": 138123485,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2222078293/image_2222078293.jpg?io=getty-c-w1536",
      "related": "BSX",
      "source": "SeekingAlpha",
      "summary": "Boston Scientific to buy Penumbra for $14.5B, expanding neurovascular thrombectomy, with long-term margin gains. Click here for more on BSX and PEN stocks.",
      "url": "https://finnhub.io/api/news?id=e65ede17258bc882b625ad3926a11922057f37e444ccd9bde58d80dc4c7212a7"
    }
  },
  {
    "ts": null,
    "headline": "Penumbra Stock Jumps. It’s Being Bought by Boston Scientific for $14.5 Billion.",
    "summary": "Boston Scientific  has agreed to acquire  Penumbra  in a cash-and-stock deal worth $14.5 billion.  The addition of  Penumbra  which makes mechanical thrombectomy products for vascular procedures, expands  Boston Scientific’s  vascular medicine business.  Penumbra shares soared 13% to $354.66 on Thursday.",
    "url": "https://finnhub.io/api/news?id=1ee6c0c927332721dee0d994ab2ed63c9f9b5c0bb4ceba2f1d16c02df0204a90",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1768484700,
      "headline": "Penumbra Stock Jumps. It’s Being Bought by Boston Scientific for $14.5 Billion.",
      "id": 138121695,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BSX",
      "source": "Yahoo",
      "summary": "Boston Scientific  has agreed to acquire  Penumbra  in a cash-and-stock deal worth $14.5 billion.  The addition of  Penumbra  which makes mechanical thrombectomy products for vascular procedures, expands  Boston Scientific’s  vascular medicine business.  Penumbra shares soared 13% to $354.66 on Thursday.",
      "url": "https://finnhub.io/api/news?id=1ee6c0c927332721dee0d994ab2ed63c9f9b5c0bb4ceba2f1d16c02df0204a90"
    }
  },
  {
    "ts": null,
    "headline": "Penumbra surges on news of $14.5 billion Boston Scientific buyout, BSX down",
    "summary": "Investing.com -- Boston Scientific Corp (NYSE:BSX) announced on Thursday that it has agreed to acquire medical technology company Penumbra (NYSE:PEN) in a transaction valued at roughly $14.5 billion, strengthening its position in cardiovascular devices.",
    "url": "https://finnhub.io/api/news?id=492e07314bd7cba635e7ad2dc8f7268eb5ee8e221206e3f2f2cfa9e02cb6f0a8",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1768484285,
      "headline": "Penumbra surges on news of $14.5 billion Boston Scientific buyout, BSX down",
      "id": 138120754,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BSX",
      "source": "Yahoo",
      "summary": "Investing.com -- Boston Scientific Corp (NYSE:BSX) announced on Thursday that it has agreed to acquire medical technology company Penumbra (NYSE:PEN) in a transaction valued at roughly $14.5 billion, strengthening its position in cardiovascular devices.",
      "url": "https://finnhub.io/api/news?id=492e07314bd7cba635e7ad2dc8f7268eb5ee8e221206e3f2f2cfa9e02cb6f0a8"
    }
  },
  {
    "ts": null,
    "headline": "Exchange-Traded Funds, Equity Futures Higher Pre-Bell Buoyed by Taiwan Semiconductor Manufacturing Guidance",
    "summary": "The broad market exchange-traded fund SPDR S&P 500 ETF Trust (SPY) was up 0.3% and the actively trad",
    "url": "https://finnhub.io/api/news?id=170721634266f581bc2681485206bad688f5552696dfd331e0f9e9c99f599fee",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1768483763,
      "headline": "Exchange-Traded Funds, Equity Futures Higher Pre-Bell Buoyed by Taiwan Semiconductor Manufacturing Guidance",
      "id": 138120740,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BSX",
      "source": "Yahoo",
      "summary": "The broad market exchange-traded fund SPDR S&P 500 ETF Trust (SPY) was up 0.3% and the actively trad",
      "url": "https://finnhub.io/api/news?id=170721634266f581bc2681485206bad688f5552696dfd331e0f9e9c99f599fee"
    }
  },
  {
    "ts": null,
    "headline": "BSX Stock May Gain From Newly Inked Deal to Buy Valencia Technologies",
    "summary": "Boston Scientific stock may rebound after agreeing to buy Valencia Technologies, adding the FDA-approved eCoin ITNS device to expand its Urology portfolio.",
    "url": "https://finnhub.io/api/news?id=ded716567a6149916faeea60ffafa88a7d91e8e567e6b74894b53d5985df1574",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1768483440,
      "headline": "BSX Stock May Gain From Newly Inked Deal to Buy Valencia Technologies",
      "id": 138121696,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BSX",
      "source": "Yahoo",
      "summary": "Boston Scientific stock may rebound after agreeing to buy Valencia Technologies, adding the FDA-approved eCoin ITNS device to expand its Urology portfolio.",
      "url": "https://finnhub.io/api/news?id=ded716567a6149916faeea60ffafa88a7d91e8e567e6b74894b53d5985df1574"
    }
  },
  {
    "ts": null,
    "headline": "Boston Scientific Will Buy Penumbra In $14.5 Billion Medtech Deal",
    "summary": "Boston Scientific will buy Penumbra for $14.5 billion, or $374 a share, expanding its cardiovascular reach. Penumbra stock jumped. Boston Scientific tumbled.",
    "url": "https://finnhub.io/api/news?id=107173b4d799d7f6a94ce30d261ebeb728f2dad0de273db6d8f53652b3a275bb",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1768483236,
      "headline": "Boston Scientific Will Buy Penumbra In $14.5 Billion Medtech Deal",
      "id": 138120756,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BSX",
      "source": "Yahoo",
      "summary": "Boston Scientific will buy Penumbra for $14.5 billion, or $374 a share, expanding its cardiovascular reach. Penumbra stock jumped. Boston Scientific tumbled.",
      "url": "https://finnhub.io/api/news?id=107173b4d799d7f6a94ce30d261ebeb728f2dad0de273db6d8f53652b3a275bb"
    }
  },
  {
    "ts": null,
    "headline": "Dow Jones Futures: Nvidia Chipmaker Taiwan Semiconductor Jumps, Lifting Sector; Goldman, Morgan Stanley Earnings Due",
    "summary": "Dow Jones futures rose early Thursday, along with S&P 500 futures and especially Nasdaq futures. Nvidia chipmaker Taiwan Semiconductor jumped early Thursday on strong earnings, giving a lift to the broader semiconductor sector.",
    "url": "https://finnhub.io/api/news?id=cde547a5296f92c7dbc671126e7a038275e6ad0b0a8ec7a6d9ea0ef5a3906af4",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1768477789,
      "headline": "Dow Jones Futures: Nvidia Chipmaker Taiwan Semiconductor Jumps, Lifting Sector; Goldman, Morgan Stanley Earnings Due",
      "id": 138119740,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BSX",
      "source": "Yahoo",
      "summary": "Dow Jones futures rose early Thursday, along with S&P 500 futures and especially Nasdaq futures. Nvidia chipmaker Taiwan Semiconductor jumped early Thursday on strong earnings, giving a lift to the broader semiconductor sector.",
      "url": "https://finnhub.io/api/news?id=cde547a5296f92c7dbc671126e7a038275e6ad0b0a8ec7a6d9ea0ef5a3906af4"
    }
  },
  {
    "ts": null,
    "headline": "Boston Scientific to Acquire Penumbra in $14.5 Billion Cash-Stock Deal",
    "summary": "Boston Scientific (BSX) said Thursday it has agreed to acquire Penumbra (PEN) in a cash and stock de",
    "url": "https://finnhub.io/api/news?id=a83ab79da1aecb80e529ed46fa600998817a1859a33eadc2ffb88ca6c4be6a7c",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1768481219,
      "headline": "Boston Scientific to Acquire Penumbra in $14.5 Billion Cash-Stock Deal",
      "id": 138120758,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BSX",
      "source": "Yahoo",
      "summary": "Boston Scientific (BSX) said Thursday it has agreed to acquire Penumbra (PEN) in a cash and stock de",
      "url": "https://finnhub.io/api/news?id=a83ab79da1aecb80e529ed46fa600998817a1859a33eadc2ffb88ca6c4be6a7c"
    }
  },
  {
    "ts": null,
    "headline": "Stocks making the biggest moves midday: Morgan Stanley, Coinbase, Taiwan Semi, Eli Lilly & more",
    "summary": "Here are some of the names making big moves in midday trading.",
    "url": "https://finnhub.io/api/news?id=2fd941cabf33dc9dbd7660425cf5ee4dbc04a90ce6bd2c87eba6f75fbd3a4bec",
    "source": "CNBC",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1768480504,
      "headline": "Stocks making the biggest moves midday: Morgan Stanley, Coinbase, Taiwan Semi, Eli Lilly & more",
      "id": 138153447,
      "image": "https://image.cnbcfm.com/api/v1/image/108247613-1767376953496-gettyimages-2253792451-US_STOCKS.jpeg?v=1768505634&w=1920&h=1080",
      "related": "BSX",
      "source": "CNBC",
      "summary": "Here are some of the names making big moves in midday trading.",
      "url": "https://finnhub.io/api/news?id=2fd941cabf33dc9dbd7660425cf5ee4dbc04a90ce6bd2c87eba6f75fbd3a4bec"
    }
  },
  {
    "ts": null,
    "headline": "Stocks to Watch Thursday: TSMC, Goldman Sachs, Nvidia, Alibaba",
    "summary": "? BlackRock (BLK), Goldman Sachs (GS), Morgan Stanley (MS): The world's biggest money manager and the two Wall Street banks are due to post earnings this morning. ↗️ TSMC (TW:2330, TSM): The world's largest contract chip maker posted another quarter of record earnings.",
    "url": "https://finnhub.io/api/news?id=91e51a705967dd2ce3f417c0db8e7140738dce576bcdb5f75e0630803b5f0ac9",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1768471033,
      "headline": "Stocks to Watch Thursday: TSMC, Goldman Sachs, Nvidia, Alibaba",
      "id": 138119750,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BSX",
      "source": "Yahoo",
      "summary": "? BlackRock (BLK), Goldman Sachs (GS), Morgan Stanley (MS): The world's biggest money manager and the two Wall Street banks are due to post earnings this morning. ↗️ TSMC (TW:2330, TSM): The world's largest contract chip maker posted another quarter of record earnings.",
      "url": "https://finnhub.io/api/news?id=91e51a705967dd2ce3f417c0db8e7140738dce576bcdb5f75e0630803b5f0ac9"
    }
  },
  {
    "ts": null,
    "headline": "Boston Scientific to Buy Penumbra for $15 Billion in Cash, Stock",
    "summary": "Boston Scientific has agreed to buy thrombectomy company Penumbra for about $15 billion in cash and stock in a deal that bolsters its cardiovascular portfolio.",
    "url": "https://finnhub.io/api/news?id=569b35f47ce4f0456d2816415e2607c299d930fba84fae891d43c7158f17915b",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1768479900,
      "headline": "Boston Scientific to Buy Penumbra for $15 Billion in Cash, Stock",
      "id": 138120760,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BSX",
      "source": "Yahoo",
      "summary": "Boston Scientific has agreed to buy thrombectomy company Penumbra for about $15 billion in cash and stock in a deal that bolsters its cardiovascular portfolio.",
      "url": "https://finnhub.io/api/news?id=569b35f47ce4f0456d2816415e2607c299d930fba84fae891d43c7158f17915b"
    }
  },
  {
    "ts": null,
    "headline": "Factbox-Major deals involving U.S. drugmakers and biotechs over the past decade",
    "summary": "Jan 15 (Reuters) - Boston Scientific is buying medical equipment maker Penumbra in a deal valued at about $14.5 billion, to expand its vascular pipeline.",
    "url": "https://finnhub.io/api/news?id=bbfd391d9f8f10e71e49dace0086a3bd81f1b55ce02d42df5ea273c7dd6618c5",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1768479722,
      "headline": "Factbox-Major deals involving U.S. drugmakers and biotechs over the past decade",
      "id": 138120717,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BSX",
      "source": "Yahoo",
      "summary": "Jan 15 (Reuters) - Boston Scientific is buying medical equipment maker Penumbra in a deal valued at about $14.5 billion, to expand its vascular pipeline.",
      "url": "https://finnhub.io/api/news?id=bbfd391d9f8f10e71e49dace0086a3bd81f1b55ce02d42df5ea273c7dd6618c5"
    }
  },
  {
    "ts": null,
    "headline": "Boston Scientific to buy Penumbra in $14.5 billion deal",
    "summary": "Jan 15 () - Boston Scientific said ​on Thursday ‌it will buy Penumbra ‌in a deal valued at about $14.5 billion to ⁠expand ‌its vascular pipeline.",
    "url": "https://finnhub.io/api/news?id=48feb46f5d37346e7dc5e133599927af35e33d19136200f978c9afd91249af50",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1768479221,
      "headline": "Boston Scientific to buy Penumbra in $14.5 billion deal",
      "id": 138120762,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BSX",
      "source": "Yahoo",
      "summary": "Jan 15 () - Boston Scientific said ​on Thursday ‌it will buy Penumbra ‌in a deal valued at about $14.5 billion to ⁠expand ‌its vascular pipeline.",
      "url": "https://finnhub.io/api/news?id=48feb46f5d37346e7dc5e133599927af35e33d19136200f978c9afd91249af50"
    }
  },
  {
    "ts": null,
    "headline": "Boston Scientific Acquiring Penumbra Was The Logical Next Step",
    "summary": "Boston Scientificâs $374/share Penumbra deal boosts mechanical thrombectomy exposure and growth. Click here to learn more about BSX stock prospects.",
    "url": "https://finnhub.io/api/news?id=98509757281b521a27d295ed96c3ac9b71bd4846417d972f948c3fcc505abeae",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1768479025,
      "headline": "Boston Scientific Acquiring Penumbra Was The Logical Next Step",
      "id": 138122352,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1097443788/image_1097443788.jpg?io=getty-c-w1536",
      "related": "BSX",
      "source": "SeekingAlpha",
      "summary": "Boston Scientificâs $374/share Penumbra deal boosts mechanical thrombectomy exposure and growth. Click here to learn more about BSX stock prospects.",
      "url": "https://finnhub.io/api/news?id=98509757281b521a27d295ed96c3ac9b71bd4846417d972f948c3fcc505abeae"
    }
  },
  {
    "ts": null,
    "headline": "Boston Scientific Corporation (BSX) M&A Call Transcript",
    "summary": "Boston Scientific Corporation (BSX) M&A Call January 15, 2026 8:00 AM ESTCompany ParticipantsLauren Tengler - Director of Investor RelationsMichael...",
    "url": "https://finnhub.io/api/news?id=916542df91634d20df230cd18e8ffa50db6968efacc17c89f0234d8d19b14a75",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1768478759,
      "headline": "Boston Scientific Corporation (BSX) M&A Call Transcript",
      "id": 138122239,
      "image": "https://static.seekingalpha.com/assets/og_image_1200-29b2bfe1a595477db6826bd2126c63ac2091efb7ec76347a8e7f81ba17e3de6c.png",
      "related": "BSX",
      "source": "SeekingAlpha",
      "summary": "Boston Scientific Corporation (BSX) M&A Call January 15, 2026 8:00 AM ESTCompany ParticipantsLauren Tengler - Director of Investor RelationsMichael...",
      "url": "https://finnhub.io/api/news?id=916542df91634d20df230cd18e8ffa50db6968efacc17c89f0234d8d19b14a75"
    }
  },
  {
    "ts": null,
    "headline": "Boston Scientific announces agreement to acquire Penumbra, Inc.",
    "summary": "Boston Scientific Corporation (NYSE: BSX) and Penumbra, Inc., (NYSE: PEN) today announced the companies have entered into a definitive agreement under which Boston Scientific will acquire Penumbra in a cash and stock transaction that values Penumbra at $374 per share, reflecting an enterprise value of approximately $14.5 billion.i",
    "url": "https://finnhub.io/api/news?id=e723557684b14486caa014207e77b0977f8235d84f77ad11c70679172710e35b",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1768478400,
      "headline": "Boston Scientific announces agreement to acquire Penumbra, Inc.",
      "id": 138119956,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BSX",
      "source": "Yahoo",
      "summary": "Boston Scientific Corporation (NYSE: BSX) and Penumbra, Inc., (NYSE: PEN) today announced the companies have entered into a definitive agreement under which Boston Scientific will acquire Penumbra in a cash and stock transaction that values Penumbra at $374 per share, reflecting an enterprise value of approximately $14.5 billion.i",
      "url": "https://finnhub.io/api/news?id=e723557684b14486caa014207e77b0977f8235d84f77ad11c70679172710e35b"
    }
  },
  {
    "ts": null,
    "headline": "Boston Scientific to acquire Penumbra for $14.5B",
    "summary": "With the planned purchase, Boston Scientific will gain several thrombectomy devices to remove clots from blood vessels.",
    "url": "https://finnhub.io/api/news?id=a521a425bc0c7244847abaeeb05d2a687e886a939b6014c93d7587831f0db314",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1768472583,
      "headline": "Boston Scientific to acquire Penumbra for $14.5B",
      "id": 138121697,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BSX",
      "source": "Yahoo",
      "summary": "With the planned purchase, Boston Scientific will gain several thrombectomy devices to remove clots from blood vessels.",
      "url": "https://finnhub.io/api/news?id=a521a425bc0c7244847abaeeb05d2a687e886a939b6014c93d7587831f0db314"
    }
  },
  {
    "ts": null,
    "headline": "Boston Scientific Corporation (BSX) Penumbra, Inc. - M&A Call - Slideshow",
    "summary": "2026-01-15. The following slide deck was published by Boston Scientific Corporation in conjunction with this event.",
    "url": "https://finnhub.io/api/news?id=f112523a489dea7114a1df054c088399f7c991f9324968c8f061665a3e06420f",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1768467726,
      "headline": "Boston Scientific Corporation (BSX) Penumbra, Inc. - M&A Call - Slideshow",
      "id": 138120953,
      "image": "https://static.seekingalpha.com/assets/og_image_1200-29b2bfe1a595477db6826bd2126c63ac2091efb7ec76347a8e7f81ba17e3de6c.png",
      "related": "BSX",
      "source": "SeekingAlpha",
      "summary": "2026-01-15. The following slide deck was published by Boston Scientific Corporation in conjunction with this event.",
      "url": "https://finnhub.io/api/news?id=f112523a489dea7114a1df054c088399f7c991f9324968c8f061665a3e06420f"
    }
  }
]